“Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma with GEMCAP and mFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes” (2026) Voprosy onkologii, 72(1), p. OF-2421. doi:10.37469/0507-3758-2026-72-1-OF-2421.